These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 28503952)

  • 1. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
    Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
    J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
    Lin WJ; Lee WC
    Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer.
    Vangara KK; Liu JL; Palakurthi S
    Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
    Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery.
    Lin WJ; Lee WC; Shieh MJ
    Carbohydr Polym; 2017 Jan; 155():101-108. PubMed ID: 27702492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
    Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
    Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
    Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
    Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S
    Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
    Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
    J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
    Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
    Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.